STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
61 hedge funds and large institutions have $137M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
+13
Holders Change %
+27.08%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
16
Increased
22
Reduced
14
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
NMC
NEA Management Company
Timonium,
Maryland
|
$17.7M |
2 |
CC
Commodore Capital
New York
|
$14.4M |
3 |
RCM
RA Capital Management
Boston,
Massachusetts
|
$35M |
4 |
SC
Samlyn Capital
New York
|
$7.28M |
5 |
VC
Vivo Capital
Palo Alto,
California
|
$7.28M |